Feeding Tube Placement in Gastric Cancer Patients
In gastric cancer patients requiring enteral feeding, use the transabdominal approach (radiographic or endoscopic introducer/Russell technique with T-tack gastropexy) rather than the standard transoral PEG pull technique to minimize the risk of tumor seeding along the tract. 1
Critical Distinction for Cancer Patients
The standard transoral "pull" technique—where the tube is pulled through the mouth, esophagus, and stomach—carries a theoretical risk of implanting malignant cells along the tract in patients with head and neck or upper gastrointestinal cancers. This is why transabdominal placement is specifically reserved for cancer patients 1.
Transabdominal Placement Procedure (Introducer/Russell Technique)
Pre-Procedure Requirements
- Patient fasting: 8 hours minimum 2
- Coagulation parameters: INR <1.5, platelets >50,000/mm³, PTT <50 seconds 2
- Antibiotic prophylaxis: Single dose of 2g cephalosporin IV (e.g., cephazolin) 2
- Informed consent: Legally valid, documented consent required 2
- IV access: For sedation (midazolam 3-5mg IV) 2
Step-by-Step Technique 1
Gastric insufflation: Inflate stomach endoscopically to appose it to the abdominal wall
Site identification:
- Locate puncture site 2 cm below costal margin at point of maximal transillumination
- Perform "one-to-one" finger indentation to confirm no overlying bowel or liver
Safe track technique:
- Insert small-bore needle with anesthetic at desired location
- Pull back on plunger while advancing to ensure no interposed bowel loops
- Apply local anesthetic
T-tack gastropexy:
- Place T-tacks to secure stomach to abdominal wall
- This is the key difference from standard PEG—provides secure fixation before tract dilation
Tract creation:
- Make small skin incision (8mm) 2
- Dilate tract through abdominal wall into stomach
Tube placement:
Alternative Approaches When Endoscopy Impossible
If tumor obstruction prevents endoscope passage:
- Fluoroscopic guidance (PFG - Percutaneous Fluoroscopic Gastrostomy) 2
- Sonographic guidance (PSG - Percutaneous Sonographically Guided Gastrostomy) 2, 4
- Laparoscopic placement (PLG - Percutaneous Laparoscopic Gastrostomy) 2
Special Considerations for Gastric Cancer
When Gastric Feeding is Contraindicated
If the tumor causes gastric outlet obstruction or prepyloric stenosis, consider:
- Direct PEJ (Percutaneous Endoscopic Jejunostomy) for feeding beyond the obstruction 2
- PEG for decompression only in cases of malignant obstruction 3, 4
One study showed PEG successfully provided gastric decompression in 21/22 patients with disseminated abdominal cancer and obstruction, with complete resolution of vomiting and nausea 4.
Contraindications Specific to Cancer Patients
- Extensive tumor infiltration at puncture site 2
- Peritoneal carcinomatosis (relative contraindication—makes finding safe window challenging but not impossible) 1
- Ascites (drain first via paracentesis; use T-tacks to improve gastric wall apposition) 1
Post-Procedure Management
Immediate Care 2
- External fixation plate should allow ≥5mm free tube movement to prevent ischemia
- Check next morning and adjust if needed
- Feeding can begin 1 hour after uncomplicated placement 2
Wound Care
- Daily sterile dressing changes for first 7 days 2
- Y-compress under external fixation plate to prevent moisture accumulation 2
- Push tube 2-3cm ventrally then pull back to resistance daily to prevent buried bumper syndrome 2
Success Rates and Complications
The procedure is successful in 95% of cancer patients 3. In the referenced cancer series:
- Mortality: 2.5% (1/40 patients—due to leakage and peritonitis) 3
- Morbidity: 15% (port infection and minor leakage managed conservatively) 3
Critical Pitfall to Avoid
Never use the standard transoral pull technique in gastric cancer patients. The most recent AGA guideline (2025) explicitly states transabdominal gastrostomy is "typically reserved for individuals with head and neck cancer, to minimize the risk of cancer seeding, and among individuals with upper gastrointestinal strictures or obstructions" 1. This applies equally to gastric cancer patients where the tube would traverse tumor tissue.